Exkivity

Exkivity

Basic Prescribing Info
Contents
Mobocertinib
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB10 - mobocertinib ; Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in